Editorial-Special issue of the 7th European workshop on lipid mediators.

Editorial-Special issue of the 7th European workshop on lipid mediators.
复制标题

第七届欧洲脂质介质研讨会社论特刊。

DOI:
10.1016/j.prostaglandins.2020.106421
复制
发表时间:
2020
影响因子:
2.9
通讯作者:
Alhouayek M
Alhouayek M
中科院分区:
生物学3区
文献类型:
--
作者:
Alhouayek M

文献摘要

相似文献

第七届欧洲脂质介质研讨会(7 EWLM)于2018年9月12日至14日在比利时布鲁塞尔的鲁汶天主教大学举行。研讨会的目的是汇集那些对生物活性脂质介质领域感兴趣的研究人员和学生。第七届两年期讲习班由Giulio Muccioli、Mireille Al Houayek、Gerard Bannenberg、Joan Clària、Per-Johan Jakobsson、Xavier Norel、Nils Helge Schebb和Chengcan Yao组织。为期三天的活动为参与者提供了一个很好的机会来展示他们的工作,并享受专家的各种演讲,年轻科学家的会议,脂质介质分析化学的教育会议,以及海报会议(请参阅完整的程序并在https://workshop-lipid下载摘要书。eu//7EWLM/index. php的?cat= Program)。来自欧洲各地和欧洲以外的200多名科学家参加了位于布鲁塞尔的鲁汶天主教大学令人印象深刻的校园研讨会。讲习班特别侧重于以下主题:一)脂质介质受体和信号传导,二)免疫和炎症反应中的脂质介质,三)血管和代谢疾病中的脂质介质,四)内源性大麻素,五)脂质组学和脂肪酸及其衍生物的进展。
The Seventh European Workshop on Lipid Mediators (7EWLM) was held at Université catholique de Louvain in Brussels, Belgium September 12-14, 2018. The aim of the workshop was to bring together those researchers and students interested in the field of bioactive lipid mediators. The seventh edition of this biennial workshop was organized by Giulio Muccioli, Mireille Al Houayek, Gerard Bannenberg, Joan Clària, Per-Johan Jakobsson, Xavier Norel, Nils Helge Schebb and Chengcan Yao. The three-day event provided a good opportunity for participants to present their work, and enjoy a variety of presentations by experts, a session for young scientists, an educational session on analytical chemistry of lipid mediators, and poster sessions (see full program and download the abstract book at https://workshop-lipid. eu//7EWLM/index. php? cat= Program). More than 200 scientists from across and outside Europe attended the workshop on the impressive campus of Université catholique de Louvain located in-Brussels. The workshop placed special focus on the following themes: i) lipid mediator receptors and signalling, ii) lipid mediators in immune and inflammatory responses, iii) lipid mediators in vascular and metabolic diseases, iv) endocannabinoids, v) lipidomics and advances in fatty acids and their derivatives.